2-Bromo-4-chlorothieno[3,2-c]pyridine-7-carbonitrile - CAS 690635-43-9
Catalog: |
BB033690 |
Product Name: |
2-Bromo-4-chlorothieno[3,2-c]pyridine-7-carbonitrile |
CAS: |
690635-43-9 |
Synonyms: |
2-bromo-4-chloro-7-thieno[3,2-c]pyridinecarbonitrile; 2-bromo-4-chlorothieno[3,2-c]pyridine-7-carbonitrile |
IUPAC Name: | 2-bromo-4-chlorothieno[3,2-c]pyridine-7-carbonitrile |
Description: | 2-Bromo-4-chlorothieno[3,2-c]pyridine-7-carbonitrile (CAS# 690635-43-9 ) is a useful research chemical. |
Molecular Weight: | 273.54 |
Molecular Formula: | C8H2BrClN2S |
Canonical SMILES: | C1=C(SC2=C1C(=NC=C2C#N)Cl)Br |
InChI: | InChI=1S/C8H2BrClN2S/c9-6-1-5-7(13-6)4(2-11)3-12-8(5)10/h1,3H |
InChI Key: | KKLKBFNWWLKRCD-UHFFFAOYSA-N |
MDL: | MFCD20484355 |
LogP: | 3.58388 |
Publication Number | Title | Priority Date |
EP-2144630-A2 | Chk1 inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies | 20070427 |
JP-2010525046-A | Methods for the treatment of hematological tumors | 20070427 |
US-2010226917-A1 | Methods for the treatment of hematologic malignancies | 20070427 |
WO-2008132500-A2 | Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies | 20070427 |
AU-2006232620-A1 | Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors | 20050406 |
Complexity: | 254 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 271.88106 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 271.88106 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 64.9 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS